Utah Admin. Code R590-287-3 - Definitions

Terms used in this rule are defined in Sections 31A-1-301 and 31A-48-102. Additional terms are defined as follows:

(1) "Drug product" means the finished dosage form of a drug that contains a drug substance, in association with other active or inactive ingredients, and that has a unique NDC.
(2) "FDA" means the United States Food and Drug Administration.
(3) "National Drug Code" or "NDC" means a three-segment code maintained by the FDA that is converted to an 11-digit format and includes a:
(a) labeler code;
(b) product code; and
(c) package code.
(4) "WAC" means wholesale acquisition cost.


Utah Admin. Code R590-287-3
Adopted by Utah State Bulletin Number 2022-11, effective 5/11/2022

State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.

No prior version found.